LEONARD JOHN M
SEC insider (Form 3/4/5 filer). CIK 0001563584. President and CEO at Intellia Therapeutics, Inc. (NTLA) and 1 other issuer. 14 reported Form 4/5 transactions since Sep 2024; latest on Aug 21, 2026. Located in CAMBRIDGE, MA.
Companies LEONARD JOHN M has filed insider reports for
- Intellia Therapeutics, Inc. (NTLA): Director, Officer, President and CEO
- IQVIA HOLDINGS INC. (IQV): Director
LEONARD JOHN M
CIK: 0001563584
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Aug 21, 2026NTLA
Intellia Therapeutics, Inc.
SaleDirect2.8K shares at avg. $13.00$36K - Aug 20, 2026NTLA
Intellia Therapeutics, Inc.
SaleDirect19.9K shares at avg. $12.60$251K - Apr 23, 2026IQV
IQVIA HOLDINGS INC.
AwardDirect1.6K shares- - Mar 1, 2026NTLA
Intellia Therapeutics, Inc.
AwardDirect156.4K shares- - Jan 5, 2026NTLA
Intellia Therapeutics, Inc.
SaleDirect34.1K shares at avg. $9.21$314K - Dec 12, 2025NTLA
Intellia Therapeutics, Inc.
ExerciseDirect8.6K shares at avg. $6.83$58K - Dec 11, 2025NTLA
Intellia Therapeutics, Inc.
SaleDirect50K shares at avg. $9.49$474K - Dec 11, 2025NTLA
Intellia Therapeutics, Inc.
SaleDirect5.4K shares at avg. $9.59$51K - Dec 11, 2025NTLA
Intellia Therapeutics, Inc.
ExerciseDirect50K shares at avg. $6.83$341K - Dec 11, 2025NTLA
Intellia Therapeutics, Inc.
SaleDirect32.8K shares at avg. $9.47$311K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 21, 2026 |  NTLA Intellia Therapeutics, Inc. | Sale | 2,785 | $13.00 | $36,205 | Direct |
| Aug 20, 2026 | NTLA Intellia Therapeutics, Inc. | Sale | 19,890 | $12.60 | $250,614 | Direct |
| Apr 23, 2026 |  IQV IQVIA HOLDINGS INC. | Award | 1,571 | - | $0 | Direct |
| Mar 1, 2026 | NTLA Intellia Therapeutics, Inc. | Award | 156,400 | - | $0 | Direct |
| Jan 5, 2026 | NTLA Intellia Therapeutics, Inc. | Sale | 34,146 | $9.21 | $314,485 | Direct |
| Dec 12, 2025 | NTLA Intellia Therapeutics, Inc. | Exercise | 8,557 | $6.83 | $58,444 | Direct |
| Dec 11, 2025 | NTLA Intellia Therapeutics, Inc. | Sale | 49,959 | $9.49 | $474,111 | Direct |
| Dec 11, 2025 | NTLA Intellia Therapeutics, Inc. | Sale | 5,355 | $9.59 | $51,354 | Direct |
| Dec 11, 2025 | NTLA Intellia Therapeutics, Inc. | Exercise | 49,959 | $6.83 | $341,220 | Direct |
| Dec 11, 2025 | NTLA Intellia Therapeutics, Inc. | Sale | 32,832 | $9.47 | $310,919 | Direct |
1-10 of 14 transactions